Literature DB >> 28419302

The Posthuman as Hollow Idol: A Nietzschean Critique of Human Enhancement.

Ciano Aydin1.   

Abstract

In this paper, the author aims to show that transhumanists are confused about their own conception of the posthuman: transhumanists anticipate radical transformation of the human through technology and at the same time assume that the criteria to determine what is "normal" and what is "enhanced" are univocal, both in our present time and in the future. Inspired by Nietzsche's notion of the Overhuman, the author argues that the slightest "historical and phenomenological sense" discloses copious variations of criteria, both diachronic and synchronic, for what can be considered "normal" and "enhanced." Radical transformation through technology does not simply enable us to become "stronger," "smarter," or "healthier," but it can and often will also change the very standard or yardstick with which we measure what counts as "stronger," "smarter," or "healthier." Put yet differently: new and emerging technologies are not neutral means but often bring about different and, from our current perspective, foreign standards for determining what are "normal" and "enhanced" capacities. Since the qualitative meanings of these terms are themselves not fixed, it is unintelligible and too reassuring to simply predict that new technologies will enhance human beings.
© The Author 2017. Published by Oxford University Press, on behalf of the Journal of Medicine and Philosophy Inc. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Nietzsche; Overhuman; human enhancement; posthuman; transhumanism

Mesh:

Year:  2017        PMID: 28419302     DOI: 10.1093/jmp/jhx002

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  1 in total

1.  What is morally at stake when using algorithms to make medical diagnoses? Expanding the discussion beyond risks and harms.

Authors:  Bas de Boer; Olya Kudina
Journal:  Theor Med Bioeth       Date:  2022-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.